Literature DB >> 9597344

Synergistic benefits of serotonin and noradrenaline reuptake inhibition.

J C Nelson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9597344

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN： 1091-4269            Impact factor:   6.505


× No keyword cloud information.
  4 in total

1.  Duloxetine withdrawal seizure.

Authors:  Abdul Qadir; Naveed Haider
Journal:  Psychiatry (Edgmont)       Date:  2006-09

2.  Comparative effects of duloxetine and desipramine on sleep EEG in healthy subjects.

Authors:  Stephan Chalon; Alvaro Pereira; Eric Lainey; François Vandenhende; John G Watkin; Luc Staner; Luc-André Granier
Journal:  Psychopharmacology (Berl)       Date:  2004-07-28       Impact factor: 4.530

3.  Duloxetine: A New Treatment for the Emotional and Physical Symptoms of Depression.

Authors:  Craig H. Mallinckrodt; David J. Goldstein; Michael J. Detke; Yili Lu; John G. Watkin; Pierre V. Tran
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2003-02

4.  Duloxetine in the treatment of major depressive disorder.

Authors:  David J Goldstein
Journal:  Neuropsychiatr Dis Treat       Date:  2007-04       Impact factor: 2.570
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.